Expanding eligibility requirements for a fourth dose of the vaccine would require regulatory approval
Physical Activity in Children Dropped During the Pandemic
Findings show 17-minute drop in moderate-to-vigorous physical activity based on global systematic literature review
Europe Endorses 4th mRNA Vaccination For Seniors
As a new wave of SARS-CoV-2 coronavirus variants dominates Europe, with increasing rates of hospital admissions, health agencies are endorsing a new round of COVID-19 vaccinations.
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) recommended today that second booster doses of mRNA COVID-19 vaccines be considered for people between 60 and 79 years old.
And for people with medical conditions putting them at high risk of severe disease.
COVID-19 Among Top 5 Causes of Death in the U.S.
As pandemic wears on, ranking of COVID-19 as a leading cause of death has increased among younger age groups
Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds
Based on data from three U.S. safety monitoring systems, adverse events were mild-to-moderate, and myocarditis occurred rarely
New Omicron Subvariant Spreading in India, United States
New mutation — BA.2.75 — has been detected in 10 other countries, including Australia, Germany, the United Kingdom, and Canada
Scientists Discover How a Protein and Enzymes Enabling Hepatitis A Virus Replication
While focusing on the viral replication cycle in the hepatitis A virus (HAV), UNC School of Medicine scientists recently discovered that replication requires specific interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases.
They also found that the oral compound RG7834 stopped replication at a critical step, making it impossible for the virus to infect liver cells.
Frontline Antibiotics Losing to Typhoid Mutations
The bacteria that causes typhoid fever is becoming increasingly resistant to antibiotics used to treat the disease, with resistant strains spreading to hundreds of countries in the past three decades, according to an analysis published by The Lancet Microbe in June 2022.
This recent study shows how resistant strains from South Asia, where the disease is endemic, have spread 200 times to other countries since 1990.
$30 Million Funding Empowers All-in-One Vaccine Candidate to Tackle Future Coronaviruses
As of early July 2022, uncertainty persists as SARS-CoV-2 coronavirus mutations continue emerging. According to the World Health Organization, the Omicron BA.x variants are now dominant worldwide.
There is a clear need for strategies to tackle emerging variants and protect populations against potential future threats to human health, says vaccine researchers from the University of Oxford and Caltech.
Immunocompromised Hospitalized With COVID-19 Have Poor Outcomes
Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status